Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Current Assets: 2017-2018

Historic Current Assets for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $38.9 million.

  • Astria Therapeutics' Current Assets fell 4.07% to $42.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $42.7 million, marking a year-over-year decrease of 4.07%. This contributed to the annual value of $38.9 million for FY2018, which is 122.84% up from last year.
  • Latest data reveals that Astria Therapeutics reported Current Assets of $38.9 million as of FY2018, which was up 122.84% from $17.5 million recorded in FY2017.
  • Over the past 5 years, Astria Therapeutics' Current Assets peaked at $38.9 million during FY2018, and registered a low of $17.5 million during FY2017.
  • Moreover, its 2-year median value for Current Assets was $28.2 million (2017), whereas its average is $28.2 million.
  • Data for Astria Therapeutics' Current Assets shows a peak YoY skyrocketed of 122.84% (in 2018) over the last 5 years.
  • Astria Therapeutics' Current Assets (Yearly) stood at $17.5 million in 2017, then spiked by 122.84% to $38.9 million in 2018.